|
GB202014851D0
|
|
SARS-COV-2 antibodies
|
|
GB201908009D0
|
|
Anti-PCSK9 antibodies
|
|
GB201906538D0
|
|
Anti-pd-1 antibodies
|
|
WO2019012015A1
|
|
Potassium channel inhibitors
|
|
GB201720351D0
|
|
Selecting for developability in drug discovery
|
|
GB201717786D0
|
|
Potassium channel inhibitors
|
|
GB201711191D0
|
|
Potassium channel inhibitors
|
|
GB201711208D0
|
|
Ion channel inhibitors
|
|
CA3010231A1
|
|
Binding members with altered diversity scaffold domains
|
|
GB201621070D0
|
|
Diversity scaffolds
|
|
GB201600341D0
|
|
Diversity scaffolds
|
|
GB201407852D0
|
|
Preparation of libraries od protein variants expressed in eukaryotic cells and use for selecting binding molecules
|
|
EP1837771A2
|
|
Monitoring of computer events
|
|
IE20000864A1
|
|
Monitoring of Computer Usage
|
